AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor. (2018)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2018.04.021
PubMed Identifier: 29746883
Publication URI: http://europepmc.org/abstract/MED/29746883
Type: Journal Article/Review
Volume: 142
Parent Publication: The Journal of allergy and clinical immunology
Issue: 3
ISSN: 0091-6749